semaglutide evoke Novo Nordisk says semaglutide, the drug used in Wegovy and Ozempic, does not slow Alzheimer's progression, despite early real-world signals that prompted two major trials involving more than 3,800 participants aged The EVOKE trials found that

Other key medical exclusions include: A prior serious allergic reaction to semaglutide or any of its ingredients

Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in Tamalpais-Homestead Valley, California who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year

Theyre similar but not exactly the same

It can be taken orally or delivered via subcutaneous injection

This suggests that using this molecule as a therapeutic approach in ALS could be beneficial (173)